- Outcomes of Treatment With Infliximab for Ulcerative Colitis and Predictors of Sustained Clinical ResponsePublication without faculty affiliation
- Outcomes of Treatment With Infliximab for Ulcerative Colitis and Predictors of Sustained Clinical Response.Publication without faculty affiliation
- Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection-an observational cohort study2021 | Second Faculty of Medicine, Third Faculty of Medicine
- Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's diseasePublication without faculty affiliation
- A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn's Disease2013 | Publication without faculty affiliation
- How to: Clostridioides difficile infection in children2022 | Publication without faculty affiliation
- Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease2013 | Faculty of Physical Education and Sport, Faculty of Mathematics and Physics, First Faculty of Medicine
- Therapeutic options for CTLA-4 Insufficiency2022 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové